DX-700 aims to serve a massive and growing market. It only needs to get a phase 1 trial going and the re-rate will be massive. Just getting to a phase one trial may well be enough for a big pharma company to want to acquire it..
Fes
Ann: Quarterly Appendix 4C and Activities Report, page-87
-
- There are more pages in this discussion • 50 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add DXB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
40.5¢ |
Change
0.000(0.00%) |
Mkt cap ! $225.9M | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 158 | 40.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 40.0¢ | 20 | 1 |
View Market Depth
| Last trade - 09.52am 11/11/2024 (20 minute delay) ? |
| DXB (ASX) Chart |
Day chart unavailable